Arrowhead Research | ARWR - Current Liabilities



Arrowhead Research reported $194.53M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Agios Pharmaceuticals USD 70.41M 18.04M Jun/2025
Alnylam Pharmaceuticals USD 1.3B 225.22M Jun/2025
Arrowhead Research USD 194.53M 26.01M Jun/2025
Incyte USD 1.28B 608.18M Jun/2025
Ionis Pharmaceuticals USD 897.24M 646.94M Jun/2025
Ligand Pharmaceuticals USD 64.73M 6.05M Jun/2025
Merck USD 26.04B 863M Jun/2025
Moderna USD 1.57B 32M Jun/2025
Novartis USD 31.71B 95M Jun/2025
Sarepta Therapeutics USD 919.95M 314.36M Jun/2025
TG Therapeutics USD 171.89M 11.68M Jun/2025
Ultragenyx Pharmaceutical USD 293.24M 1.58M Jun/2025
Vertex Pharmaceuticals USD 4.14B 355.2M Jun/2025
Xencor USD 96.08M 7.65M Jun/2025